Selank 10mg/vial 1 Vial by Master Pharma

Usage

1. Gather supplies: Selank 10mg vial, bacteriostatic water (BW), 2 mL syringe for reconstitution, 29–31 gauge insulin syringe for injection, alcohol swabs, and a sharps container.
2. Swab the vial septum with an alcohol wipe and allow it to dry for 10 seconds before inserting any needle.
3. Draw 2 mL of bacteriostatic water into the reconstitution syringe, then inject it slowly down the inner wall of the Selank vial — not directly onto the lyophilised cake.
4. Swirl the vial gently in a circular motion for 20–30 seconds until the powder dissolves fully into a clear, colourless solution; do not shake.
5. Draw your calculated dose into the insulin syringe (10 units = 500 mcg at 5 mg/mL), pinch the skin at your chosen subcutaneous site, insert the needle at a 45° angle, and inject slowly over 5–10 seconds.
6. Withdraw the needle, apply light pressure with a clean swab, recap and dispose of the needle in a sharps container, and return the vial to the refrigerator at 2–8 °C immediately after use.

Warnings

Frequently asked questions

What diluent should I use to reconstitute Selank 10mg peptide vials?

Bacteriostatic water (BW) is the correct diluent for Selank 10mg vials intended for multi-dose use. BW contains 0.9% benzyl alcohol, which inhibits microbial growth and keeps the reconstituted solution stable for up to 28 days when refrigerated at 2–8 °C. Sterile water for injection is only appropriate if the entire vial will be used in a single session, as it carries no preservative activity.

How long can I store a reconstituted Selank vial in the fridge before it degrades?

A Selank vial reconstituted with bacteriostatic water should be used within 28 days when stored continuously at 2–8 °C and protected from light. Beyond that window, oxidative degradation and potential microbial contamination make the solution unsuitable. Lyophilised (unreconstituted) vials remain stable for up to 12 months at 2–8 °C or longer when kept at −20 °C.

How does subcutaneous peptide injection differ from intramuscular injection for Selank?

Subcutaneous injection deposits the peptide into the adipose layer just beneath the skin, producing a slower, more diffuse absorption profile compared to intramuscular injection, which delivers compound directly into well-vascularised muscle tissue. For Selank, subcutaneous administration is standard practice; it requires a short 29–31 gauge needle at a 45° angle rather than the longer needles used intramuscularly, and it is associated with less discomfort and lower bleed risk.

What concentration does a 10mg Selank vial give me per insulin syringe unit after reconstitution?

Adding 2 mL of bacteriostatic water to a 10mg Selank vial produces a 5 mg/mL (5,000 mcg/mL) solution. On a standard 100-unit insulin syringe, each 10 units drawn equals 500 mcg of Selank. This ratio makes precise dosing straightforward without additional calculations, and the 1 mL syringe volume comfortably accommodates the working doses used in most research protocols.

How should I rotate subcutaneous injection sites when using Selank daily?

Site rotation prevents localised lipodystrophy and tissue irritation that can result from repeated injections into the same spot. The abdomen (at least two inches from the navel), outer thigh, and lateral deltoid are the three primary rotation zones for subcutaneous peptide administration. Cycling sequentially through these areas — and moving at least one centimetre from the previous injection point within each zone — allows adequate tissue recovery between doses. (2) angle_used

Manufacturer

Selank sits within the peptide injectable segment of Master Pharma's catalogue — the segment that, in terms of active SKU count, represents the brand's most technically demanding production line, given the precision lyophilisation conditions and sterility standards each vial format requires. The release protocol applied to Selank vials is specific rather than generic: HPLC active-content verification is run against a reference standard matched to Selank's chromatographic profile, and LAL endotoxin quantification is performed lot-specifically rather than on a pooled-batch basis. The resulting Certificate of Analysis is tied to the batch number printed on the vial's packaging — meaning the analytical data a customer receives reflects the exact production lot in hand, not an averaged result from a broader production run.